Fan. Zoetmulder et Ph. Sugarbaker, PATTERNS OF FAILURE FOLLOWING TREATMENT OF PSEUDOMYXOMA PERITONEI OF APPENDICEAL ORIGIN, European journal of cancer, 32A(10), 1996, pp. 1727-1733
Pseudomyxoma peritonei is a rare disease caused by a perforated adenom
a of the appendix. It results in extensive accumulation of mucinous tu
mour at specific locations within the abdomen and pelvis. The study wa
s undertaken to examine patterns of recurrence in patients with grade
I disease treated by cytoreductive surgery and early postoperative int
raperitoneal chemotherapy. After a median followup of 1.9 years (range
0.5-7.4 years) 42 out of 118 patients had recurred. In 32 patients, d
etailed information regarding the anatomical location of recurrent tum
our from CT-scan and second-look laparotomy were available and these f
orm the basis of this study. The volume of recurrent tumour was record
ed at eight abdominal sites, the laparotomy scar and at suture lines.
Patient, tumour and treatment factors were analysed for a possible rel
ationship with the pattern of recurrence. With recurrence, true metast
atic disease was observed in 3 patients and a distinctly higher grade
of intraperitoneal tumour in another patient. Pleural spread of pseudo
myxoma was found in 6 patients, always related to entering the pleural
cavity during cytoreduction (P = 0.000031). Two abdominal sites consi
stently had an increase in tumour deposits at re-operation as compared
to the initial cytoreduction. Small bowel had large deposits at re-op
eration in 17% versus 3% at initial cytoreduction and retroperitoneal
surfaces 10% versus 0%. Recurrences were most frequent in the left sub
hepatic/lesser omentum area (28%), while the right subdiaphragmatic ar
ea (3%) was least involved. Pseudomyxoma peritonei recurrence in the l
aparotomy scar was found in 15/29 patients (52%), significantly more f
requent if tumour had been present at former laparotomy scars during c
ytoreduction (P = 0.042). In 15/25 (60%) of patients, recurrences were
found at suture lines. Differences in the completeness of cytoreducti
on, inadequate distribution of intraperitoneal chemotherapy to upper a
bdominal and small bowel surfaces, and entrapment of tumour within sut
ure lines were thought to be causal factors consistent with this patte
rn of recurrence. Consequences for future treatment strategies are dis
cussed. Copyright (C) 1996 Published by Elsevier Science Ltd